Blackmores traded at 91.44 this Friday July 21st, increasing 0.03 or 0.03 percent since the previous trading session. Looking back, over the last four weeks, Blackmores gained 2.89 percent. Over the last 12 months, its price rose by 19.55 percent. Looking ahead, we forecast Blackmores to be priced at 89.46 by the end of this quarter and at 83.76 in one year, according to Trading Economics global macro models projections and analysts expectations.
Blackmores Limited is an Australia-based natural healthcare company. The Company is engaged in developing, manufacturing, sales, and marketing of natural health products for humans and animals including vitamins, and herbal and mineral nutritional supplements. The Company's segments include Australia and New Zealand (ANZ), China, International. ANZ segment includes BioCeuticals and PAW brands sold across Australia and New Zealand. China segment consists of Blackmores and PAW by Blackmores brands in China and China Export Division. The International segment comprises of Indonesia, Thailand, Malaysia, Singapore, Hong Kong (China), Taiwan (China), Korea, Vietnam, Pakistan, and Kazakhstan.